Keeping modern in medicine: Pharmaceutical promotion and physician education in postwar america

Jeremy Greene, Scott H. Podolsky

Research output: Contribution to journalArticle

Abstract

Recent critiques of the role of pharmaceutical promotion in medical practice invoke a nostalgic version of 1950s and 1960s medicine as representing an uncomplicated relationship between an innovative pharmaceutical industry and an idealistic and sovereign medical profession-a relationship that was later corrupted by regulatory or business practice changes in the 1980s or 1990s. However, the escalation of innovation and promotion in the pharmaceutical industry at mid-century had already provoked a broader crisis of overflow in medical education in which physicians came to use both commercial and professional sources in an attempt to "keep modern" by incorporating emerging therapeutics into their practices. This phenomenon was simultaneously a crisis for the medical profession-playing a key role in attempts to inculcate a "rational therapeutics"-and a marketing opportunity for the pharmaceutical industry, and produced the structural foundations for contemporary debates regarding the role of pharmaceutical promotion in medical practice. Tracing the issue from the advent of the wonder drugs through today's concerns regarding formal CME, we document how and why the pharmaceutical industry was allowed (and even encouraged) to develop and maintain the central role it now plays within postgraduate medical education and prescribing practice.

Original languageEnglish (US)
Pages (from-to)331-377
Number of pages47
JournalBulletin of the History of Medicine
Volume83
Issue number2
StatePublished - 2009
Externally publishedYes

Fingerprint

Modern 1601-history
Drug Industry
Physicians
Education
Medical Education
Pharmaceutical Preparations
Marketing
Medicine
Pharmaceutical Industry
Pharmaceuticals
Therapeutics
Medical Profession
Medical Practice

Keywords

  • American medical association
  • Kefauver hearings
  • Ontinuing medical education
  • Pharmaceutical industry
  • Pharmaceutical promotion
  • Postgraduate medical education
  • Prescribing behavior

ASJC Scopus subject areas

  • History
  • Medicine (miscellaneous)
  • Nursing(all)

Cite this

Keeping modern in medicine : Pharmaceutical promotion and physician education in postwar america. / Greene, Jeremy; Podolsky, Scott H.

In: Bulletin of the History of Medicine, Vol. 83, No. 2, 2009, p. 331-377.

Research output: Contribution to journalArticle

@article{11ce2a5f5230479e94cc084ed1e9b353,
title = "Keeping modern in medicine: Pharmaceutical promotion and physician education in postwar america",
abstract = "Recent critiques of the role of pharmaceutical promotion in medical practice invoke a nostalgic version of 1950s and 1960s medicine as representing an uncomplicated relationship between an innovative pharmaceutical industry and an idealistic and sovereign medical profession-a relationship that was later corrupted by regulatory or business practice changes in the 1980s or 1990s. However, the escalation of innovation and promotion in the pharmaceutical industry at mid-century had already provoked a broader crisis of overflow in medical education in which physicians came to use both commercial and professional sources in an attempt to {"}keep modern{"} by incorporating emerging therapeutics into their practices. This phenomenon was simultaneously a crisis for the medical profession-playing a key role in attempts to inculcate a {"}rational therapeutics{"}-and a marketing opportunity for the pharmaceutical industry, and produced the structural foundations for contemporary debates regarding the role of pharmaceutical promotion in medical practice. Tracing the issue from the advent of the wonder drugs through today's concerns regarding formal CME, we document how and why the pharmaceutical industry was allowed (and even encouraged) to develop and maintain the central role it now plays within postgraduate medical education and prescribing practice.",
keywords = "American medical association, Kefauver hearings, Ontinuing medical education, Pharmaceutical industry, Pharmaceutical promotion, Postgraduate medical education, Prescribing behavior",
author = "Jeremy Greene and Podolsky, {Scott H.}",
year = "2009",
language = "English (US)",
volume = "83",
pages = "331--377",
journal = "Bulletin of the History of Medicine",
issn = "0007-5140",
publisher = "Johns Hopkins University Press",
number = "2",

}

TY - JOUR

T1 - Keeping modern in medicine

T2 - Pharmaceutical promotion and physician education in postwar america

AU - Greene, Jeremy

AU - Podolsky, Scott H.

PY - 2009

Y1 - 2009

N2 - Recent critiques of the role of pharmaceutical promotion in medical practice invoke a nostalgic version of 1950s and 1960s medicine as representing an uncomplicated relationship between an innovative pharmaceutical industry and an idealistic and sovereign medical profession-a relationship that was later corrupted by regulatory or business practice changes in the 1980s or 1990s. However, the escalation of innovation and promotion in the pharmaceutical industry at mid-century had already provoked a broader crisis of overflow in medical education in which physicians came to use both commercial and professional sources in an attempt to "keep modern" by incorporating emerging therapeutics into their practices. This phenomenon was simultaneously a crisis for the medical profession-playing a key role in attempts to inculcate a "rational therapeutics"-and a marketing opportunity for the pharmaceutical industry, and produced the structural foundations for contemporary debates regarding the role of pharmaceutical promotion in medical practice. Tracing the issue from the advent of the wonder drugs through today's concerns regarding formal CME, we document how and why the pharmaceutical industry was allowed (and even encouraged) to develop and maintain the central role it now plays within postgraduate medical education and prescribing practice.

AB - Recent critiques of the role of pharmaceutical promotion in medical practice invoke a nostalgic version of 1950s and 1960s medicine as representing an uncomplicated relationship between an innovative pharmaceutical industry and an idealistic and sovereign medical profession-a relationship that was later corrupted by regulatory or business practice changes in the 1980s or 1990s. However, the escalation of innovation and promotion in the pharmaceutical industry at mid-century had already provoked a broader crisis of overflow in medical education in which physicians came to use both commercial and professional sources in an attempt to "keep modern" by incorporating emerging therapeutics into their practices. This phenomenon was simultaneously a crisis for the medical profession-playing a key role in attempts to inculcate a "rational therapeutics"-and a marketing opportunity for the pharmaceutical industry, and produced the structural foundations for contemporary debates regarding the role of pharmaceutical promotion in medical practice. Tracing the issue from the advent of the wonder drugs through today's concerns regarding formal CME, we document how and why the pharmaceutical industry was allowed (and even encouraged) to develop and maintain the central role it now plays within postgraduate medical education and prescribing practice.

KW - American medical association

KW - Kefauver hearings

KW - Ontinuing medical education

KW - Pharmaceutical industry

KW - Pharmaceutical promotion

KW - Postgraduate medical education

KW - Prescribing behavior

UR - http://www.scopus.com/inward/record.url?scp=68249114273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68249114273&partnerID=8YFLogxK

M3 - Article

C2 - 19502716

AN - SCOPUS:68249114273

VL - 83

SP - 331

EP - 377

JO - Bulletin of the History of Medicine

JF - Bulletin of the History of Medicine

SN - 0007-5140

IS - 2

ER -